Net revenue rose 57% to $509 million in Oddity’s first fiscal year as a publicly traded company.

“I truly believe there is no limit to what we can build at Oddity,” Oran Holtzman, co-founder and CEO, said when the company released its full-year fiscal performance.

More recently, in Q1, net revenue rose 28% year-over-year to $212 million. During the quarter, Oddity said it achieved “excellent, profitable growth” at both Il Makiage and SpoiledChild across markets and products.

Further, officials said the company continues to grow its molecule discovery platform known as Oddity Labs.

There are two more brands in the Oddity pipeline—both of which have targeted rollouts slated for 2025. The first to hit the market will be a medical-grade skin and body brand. Oddity has yet to share details on the other launch.

New York, NY
www.oddity.com

Sales: $325 million

With headquarters in New York City and an R&D center in Tel Aviv, Oddity is the consumer-tech platform behind Il Makiage, a makeup brand, and more recently, Spoiled Child, a skin and hair care brand that debuted this year. Oddity says it uses cutting-edge data science to identify consumer needs and develops solutions in the form of beauty, wellness and tech products. Tech products include Powermatch, an AI- and machine learning-driven matching engine to deliver consumers the perfectly-matched products for them; Kenzza, a patented creator-powered in-house media platform that represents one of the largest libraries of bespoke beauty media content in the world; Hyperspectral Vision, a patented hyperspectral image recovery software; and SpoiledBrain—an AI- and machine learning-driven matching engine to pair consumers with wellness products.

In April, Oddity acquired Boston-based Revela, a biotechnology startup and forerunner in AI-based molecule discovery for beauty and wellness indications, for $76 million. The acquisition will allow for the establishment of Oddity Labs in Boston with an additional $25 million investment for its frontier lab. The business combination will boost the development and expansion of proprietary, science-backed, clinically-tested and highly-efficacious products.

Oddity earlier this year closed a $130 million private round. It also launched a digital security token built on the Ethereum blockchain. According to the company, the token is a digital security that automatically converts into Oddity Class A ordinary shares at the time of an IPO.

Sales: $268 million (est.)

With HQ in New York City and an R&D center in Tel Aviv, Oddity is the consumer-tech platform behind Il Makiage, a makeup brand, and more recently, Spoiled Child, a skin and hair care brand that debuted this year.

Spoiled Child is said to match consumers to their products using a proprietary machine learning engine that offers tailored recommendations. Oddity invested heavily in the Spoiled Child launch—billboards were plastered in Times Square, on sidewalks and inside subway trains throughout New York City.

In January, Oddity closed a $130 million private round and it launched a digital security token built on the Ethereum blockchain. According to the company, the token is a digital security that automatically converts into Oddity Class A ordinary shares at the time of an IPO.

Spoiled Child is a new brand from the maker of Il Makiage.